Myopia management starts 1 day at a time
More than 40% of Americans are myopic – and that number is increasing at an alarming rate, especially among school-age children.* Fortunately, there’s a treatment that can help: MiSight® 1 day is the first and only soft contact lens FDA-approved** to slow the progression of myopia in children, aged 8-12 at initiation of treatment.1
Multinational study: What we learned
CooperVision® undertook a rigorous, multi-year, multi-country study to track how the MiSight® 1 day contact lens affected myopia progression in children aged 8-12 at the initiation of treatment.1† After three years, the study concluded the lens effectively slowed myopia progression by 59% and slowed the rate at which the eye lengthens by 52% compared to children in the control group wearing a single-vision 1-day lens.2
A revolutionary treatment
MiSight® is an FDA-approved** lens available as part of a comprehensive myopia management approach offered by CooperVision® and participating Vision Source® practices. The ActivControlTM Technology in MiSight® 1 day utilizes an optic zone concentric ring design with alternating vision correction and treatment zones. The design allows the child to see clearly while benefitting from the treatment effect.
Resources to build your practice
Check out CooperVision®'s new waiting room video featuring MiSight® 1 day spokesperson and wearer Alan Kim below, and download the video for your own use in the further insights section to the right. Kim has myopia and shares his MiSight® 1 day experience, demonstrating how he can wear contact lenses successfully at his age and enjoy the benefits of increased confidence and freedom in everyday activities.
Discover more
-
FRESH DAY®
Exclusively branded for Vision Source®. Sustainably made in Costa Rica.
-
MYOPIA MANAGEMENTMYOPIA MANAGEMENTHelping ECPs and parents slow the progression of myopia in children age 8-12 years at initiation of treatment1** through our Brilliant FuturesTM program.
-
REVEAL™
Exclusively branded for Vision Source®. Offering you and your patients more.
-
AQUACLEAR®
New look meets enduring advantages. AQUACLEAR® is where it all comes together.
* Cooper, Y. (2019, May 1). With Childhood Myopia Rates on the Rise, the American Optometric Association Highlights the Importance of Early Intervention through Annual Eye Exams. Retrieved from https://www.aoa.org/newsroom/m...
** Indications for Use: MiSight® (omafilcon A) daily wear single use Soft Contact Lenses are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
† Compared to a single vision 1 day lens over a 3 year period.
References:
1 Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8): 556-567.
2 CooperVision data on file 2019. How much do you like wearing your contact lenses? 87/97 (90%) Top box ‘I like contact lenses the best’ Subjective response @60M.
